Therapeutic Potential of Astaxanthin Against Cadmium-Induced Hepatic Failure: An Experimental Study Astaxanthin and Cadmium Hepatotoxicity
Iranian Journal of Pharmaceutical Sciences,
Vol. 18 No. 1 (2022),
15 January 2022
,
Page 1-7
https://doi.org/10.22037/ijps.v18.40214
Abstract
Cadmium is a toxic metal that can lead to liver failure in humans and animals. Astaxanthin (ASX) is one of the well-known xanthophyll carotenoids in food that has remarkable antioxidant properties. Hence, this study investigated the effect of ASX against cadmium-induced hepatic failure. Twenty-four mice were divided into four groups of six each and treated intraperitoneally as follows: group 1 (sham) received normal saline and olive oil; group 2 received 10 mg/kg/day of ASX; groups 3 and 4 were treated with cadmium (1 mg/kg/day) and ASX (10 mg/kg/day) + cadmium (1 mg/kg/day), respectively. After 14 consecutive days, mice were sacrificed and blood and liver samples were isolated for histopathological and biochemical experiments. Our findings showed a significant increase in serum alanine aminotransferase level, as a hepatic marker, following cadmium administration (p < 0.05). In this regard, cadmium led to hepatic leukocyte infiltration, dilated sinusoids, and increased hepatic metallothionein level (p < 0.01). Following the administration of ASX, a significant improvement was found in the metallothionein level and hepatic enzymes alongside histopathologic alterations. The present study revealed that the administration of ASX could prevent cadmium-induced hepatic failure, which may be related to the antioxidant properties of this carotenoid.
- Cadmium
- Astaxanthin
- Liver
- Metallothionein
- Mice
- Enzyme
How to Cite
References
[2] Cupertino MC, Novaes RD, Santos EC, Neves AC, Silva E, Oliveira JA and Matta SLP. Differential susceptibility of germ and leydig cells to cadmium-mediated toxicity: impact on testis structure, adiponectin levels, and steroidogenesis. Oxid. Med. Cell. Longev. (2017): 2017.
[3] Moradkhani S, Rezaei-Dehghanzadeh T and Nili-Ahmadabadi A. Rosa persica hydroalcoholic extract improves cadmium-hepatotoxicity by modulating oxidative damage and tumor necrosis factor-alpha status. Environ. Sci. Pollut. Res. (2020) 27: 31259-68.
[4] Allam NG, Ali EMM, Shabanna S and Abd-Elrahman E. Protective efficacy of Streptococcus thermophilus against acute cadmium toxicity in mice. Iran J. Phrm. Res. (2018) 17 (2): 695-707.
[5] Arslan Z, Ates M, McDuffy W, Agachan MS, Farah IO, Yu WW and Bednar AJ. Probing metabolic stability of CdSe nanoparticles: alkaline extraction of free cadmium from liver and kidney samples of rats exposed to CdSe nanoparticles. J. Hazard. Mater. (2011) 192 (1): 192-9.
[6] Nair AR, DeGheselle O, Smeets K, Van Kerkhove E and Cuypers A. Cadmium-induced pathologies: where is the oxidative balance lost (or not)? Int. J. Mol. Sci.( 2013) 14 (3): 6116-43.
[7] Wahid M, Prasarnpun S and Yimtragool N. Cadmium accumulation and metallothionein gene expression in the liver of swamp eel (Monopterus albus) collected from the Mae Sot District, Tak Province, Thailand. Genet. Mol. Res. (2017) 16 (3).
[8] Hennigar SR, Kelley AM and McClung JP. Metallothionein and zinc transporter expression in circulating human blood cells as biomarkers of zinc status: a systematic review. Adv. Nutr. (2016) 7 (4): 735-746.
[9] Kobori M, Takahashi Y, Sakurai M, Ni Y, Chen G, Nagashimada M, Kaneko S and Ota T. Hepatic transcriptome profiles of mice with diet-induced nonalcoholic steatohepatitis treated with astaxanthin and vitamin E. Int. J. Mol. Sci. (2017) 18 (3): 593.
[10] Galasso C, Orefice I, Pellone P, Cirino P, Miele R, Ianora A, Brunet C and Sansone C. On the neuroprotective role of astaxanthin: new perspectives? Mar. Drugs ( 2018) 16 (8): 247.
[11] Kim SH and Kim H. Inhibitory effect of astaxanthin on oxidative stress-induced mitochondrial dysfunction-a mini-review. Nutrients (2018) 10 (9): 1137.
[12] McCall B, McPartland CK, Moore R, Frank-Kamenetskii A and Booth BW. Effects of astaxanthin on the proliferation and migration of breast cancer cells in vitro. Antioxidants (2018) 7 (10): 135.
[13] Omidifar N, Nili-Ahmadabadi A, Gholami A, Dastan D, Ahmadimoghaddam D and Nili-Ahmadabadi H. Biochemical and Histological Evidence on the Protective Effects of Allium hirtifolium Boiss (Persian Shallot) as an Herbal Supplement in Cadmium-Induced Hepatotoxicity. Evid. Based Complement. Alternat. Med. ( 2020): 2020.
[14] Nili-Ahmadabadi A, Alibolandi P, Ranjbar A, Mousavi L, Nili-Ahmadabadi H, Larki-Harchegani A, Ahmadimoghaddam D and Omidifar N. Thymoquinone attenuates hepatotoxicity and oxidative damage caused by diazinon: an in vivo study. Res. Pharm. Sci. (2018) 13 (6): 500-8.
[15] Zhai Q, Wang G, Zhao J, Liu X, Narbad A, Chen YQ, Zhang H, Tian F and Chen W. Protective effects of Lactobacillus plantarum CCFM8610 against chronic cadmium toxicity in mice indicate routes of protection besides intestinal sequestration. Appl. Environ. Microbiol. (2014) 80 (13): 4063-71.
[16] Fahim MA, Nemmar A, Singh S, Shafiullah M, Yasin J and Hasan MY. L-2-Oxothiazolidine-4-carboxylic acid mitigates the thromboembolic effects and systemic toxicity induced by sub-acute exposure to cadmium in mice. Int. J. Clin. Exp. Med. (2016) 9 (8): 15764-71.
[17] Zeinvand-Lorestani H, Nili-Ahmadabadi A, Balak F, Hasanzadeh G and Sabzevari O. Protective role of thymoquinone against paraquat-induced hepatotoxicity in mice. Pestic. Biochem. Physiol. (2018) 148: 16-21.
[18] Turkez H, Geyikoglu F, Yousef MI, Togar B, Gürbüz H, Celik K, Akbaba GB and Polat Z. Hepatoprotective potential of astaxanthin against 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in cultured rat hepatocytes. Toxicol. Ind. Health (2012) 30 (2): 101-12.
[19] Islam MA, Al Mamun MA, Faruk M, Islam MTU, Rahman MM, Alam MN, Rahman AFM, Reza HM and Alam MDA. Astaxanthin ameliorates hepatic damage and oxidative stress in carbon tetrachloride-administered rats. Pharmacogn. Res. (2017) 9 (Suppl 1): 84-91.
[20] Zhu X, Chen Y, Chen Q, Yang H and Xie X. Astaxanthin promotes Nrf2/ARE signaling to alleviate renal fibronectin and collagen IV accumulation in diabetic rats. J. Diabetes Res. (2018) : 2018.
[21] Shen M, Chen K, Lu J, Cheng P, Xu L, Dai W, Wang F, He L, Zhang Y, Chengfen W, Li J, Yang J, Zhu R, Zhang H, Zheng Y, Zhou Y and Guo C. Protective effect of astaxanthin on liver fibrosis through modulation of TGF-1 expression and autophagy. Mediators Inflamm. (2014) : 2014.
[22] Shibata A, Kiba Y, Akati N, Fukuzawa K and Terada H. Molecular characteristics of astaxanthin and β-carotene in the phospholipid monolayer and their distributions in the phospholipid bilayer. Chem. Phys. lipids (2001) 113 (1-2): 11-22.
[23] Hernández-Marin E, Barbosa A and Martínez A. The metal cation chelating capacity of astaxanthin. Does this have any influence on antiradical activity? Molecules (2012) 17 (1): 1039-54.
- Abstract Viewed: 347 times
- IJPS_Volume 18_Issue 1_Pages 1-7 Downloaded: 285 times